Submission deadline has passed.
DEADLINE:
The deadline for submission of
Late-Breaking Research Report proposals is
February 10, 2012 at 11:59 p.m. CT.
PROPOSAL LIMIT:
An individual cannot be listed as
a presenter on more than 2 submitted
proposals (panels, workshops, methodological
innovations and/or individual/late-breaking
research presentations and pharma pipeline
presentations) per year, and cannot be listed
for more than 4 total roles, i.e., chair,
co-chair, presenter, or discussant. An
individual may be a co-author on any number of
submitted abstracts.
SPECIAL CHARACTERS:
If you use Greek letters, they
will need to be spelled out instead of using the
character.
STEPS FOR SUBMISSION
STEP 1:
Prospective presenters will submit their contact
information and the contact information for
co-author.
STEP 2:
The title, abstract, submission category and a
minimum of two learning objectives are to be
entered or uploaded into the submission site.
The abstract will provide a
general overview of the proposed presentation
(limited to 3000 characters, including title,
spaces, learning objectives and literature
reference). The abstract is a concise
description of the specific purpose, content,
methodology, results, and importance of the
proposed talk. Please state specific findings
to be presented and the importance of such
findings for advancing the field. Literature
references - Each submission must list two
relevant literature references. Follow the
American Journal of Psychiatry
style—see:
http://ajp.psychiatryonline.org
STEP 3:
Upload the presenter’s CV/Brief Biography (Word
or PDF).
STEP 4:
Complete the COI disclosure for
the presenter AND ALL co-authors.
STEP 5:
Proof read the abstract
submission.
STEP 6:
Submit. If you have not completed all required
sections/items you will not be able to submit
your proposal. In the case of missing items, you
will be prompted to enter the missing
information.
For policy questions, please
contact the ASCP Executive Office at
615-649-3085 or
info@ascpp.org
Presentation Guidelines for Late-Breaking
Research Report Session
Each research
report will be a 10 minute presentation followed
by a 5 minute Q&A session.
Presentations
are solely education based. The use of any
advertising, trade names, or product-group
message association is prohibited; this rule
will be strictly enforced.
The research
reporter’s AND ALL co-authors' disclosures must
appear on the first slide of the presentation.
Slides will be reviewed in the speaker ready
room to endure compliance.
Logos (Company,
Institution, University, etc) are not permitted
to appear on meeting materials, including
presentation slides.
Timers are
provided. It is up to the chair of the session
to keep each presenter limited to their time
allotted.
Audiovisual
equipment will be available: laptop, LCD
projector, laser pointer, podium, and
microphone.
Conflict of Interest
Your presentation, should it be
accepted, is an important part of NCDEU's
educational component and will be designated for
continuing education credit. It is the policy of
the Accreditation Council for Continuing Medical
Education (ACCME) that any individual who
participates in a continuing education activity
must disclose any financial interest or other
relationships that have occurred within the past
12 months. ACCME considers relationships of the
individual involved in the CME activity to
include financial relationships of a spouse or
partner.
Please note that the ACCME has not set a minimum
amount for relationships to be significant and
it states that inherent in any amount is the
incentive to maintain or increase the value of
the relationship. Examples of financial
interests include salary, royalty, intellectual
property rights, consulting fee, honoraria,
ownership interest (including stocks, stock
options or other ownership interest, excluding
diversified mutual funds). Examples of other
relationships include grants, research support,
medication, assessment tools, and any
relationship(s) with the manufacturer(s) of any
commercial product(s) or relationship(s) with
any organization(s) with an interest in clinical
research or training that may be discussed in
the educational presentation.
The ACCME Commercial Support Standards insist on
the separation of education from all promotional
activities, materials, and messages.
Presentations are an integral part of the
education and as such cannot have any
advertising, trade names or product-group
messages associated with them. Presenters are
required to give a balanced view of therapeutic
options. A "balanced view" means that
recommendations or emphasis must fairly
represent a reasonable and valid interpretation
of the information available on the subject and
no single product or service is over represented
in the education activity and that other equal
and competing products or services are included.
It is preferable to use generic names whenever
possible, if it is necessary to use a trade
name, then please use those of several
companies. Further, should your presentation
include discussion of any unlabeled or
investigational use of a commercial product, you
are required to disclose this to the
participants.
Submission deadline has passed.
